genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
Dry eye
News
Corneal Injury Treatment Might Arise from Study That IDs Gene and Protein That Could Be Therapeutic Targets
Drug Discovery
Lineage 2.0: Cell Therapy Developer Eyes Next Phase after Genentech Collaboration for Dry AMD
Genome Editing
Gene Therapy Discovery Offers Hope for Patients with AMD
Industry News
Allergan Eliminating 1400 Jobs as Dry-Eye Drug Faces Generic Competition
Drug Discovery
Novartis Licenses Clinical-Stage Protein Therapeutic from Lubris for Ophthalmology
News
Allergan Swallows Poison Pill as Valeant Plans R&D Cuts
News
Shire Reports Mixed Phase III Results for Dry Eye Candidate
News
Lee’s Pharma to Potentially Develop Three Peptide Drugs from RegeneRx in China, Hong Kong, and Macau
Industry News
Dompé Acquires Remaining 51% of Anabasis for Lead NGF Ophthalmology Candidate
Industry News
Santen Starts Acquisition Bid for 50.55% Stake in Ophthalmic Drugs Firm Novagali
1
2
Page 1 of 2
Scroll Up
Scroll Up
